Botanical species · safety record

Plantago asiatica

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 genotoxicity assay for Plantago asiatica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Plantago asiatica L.

3Constituent measurements

1Safety records

4Cited sources

291Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 291 licensed products naming Plantago asiatica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Fruit
Herb
Herb top
New material
Plantago asiatica seed
Plantago asiatica whole plant
Prepared seed
Rhizome

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Eugenol	Leaves	Essential oil	1.97 Percent	GC-MS	Resolve DOI
Camphor	Roots and other underground parts	Essential oil	—	Unspecified	No resolvable identifier
Indole alkaloids	Seed	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	chromosome aberration	chromosome aberration assay	Hamster (as animal)	With and without	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Koo, Yun-Chang., Jung, Sung-Hoon., Yang, Ji-Hee., Ryu, Yung-Sun., Kim, Eun-Jin., Lee, Kwang-Won. Cytogenetic Investigation of Chromosomal Aberrations in Cells Treated with Plantamajoside from Plantago asiatica. PHYTOTHERAPY RESEARCH, 2009, vol. 23, no. 10, p. 1479-1481. DOI
Gao, Zhong-Hua., Kong, Ling-Mei., Zou, Xi-Sheng., Shi, Yi-Ming., Shang, Shan-Zhai., Luo, Huai-Rong., Liang, Cheng-Qin., Li, Xiao-Nian., Li, Yan., Du, Xue., et al. Four new indole alkaloids from Plantago asiatica. Natural Products and Bioprospecting, 2013, p. 249-254.
Kameoka, Hiromu., Wang, Chi-Pao., Yokoyama, Kyotatsu. The constituents of the essential oil from Plantago asiatica L. Yakugaku zasshi, 1979, p. 95-97.
Chung, Mi Ja., Park, Kuen Woo., Kim, Kyoung Heon., Kim, Cheong-Tae., Baek, Jun Pill., Bang, Kyong-Hwan., Choi, Young-Mi., Lee, Sung-Joon. Asian plantain (Plantago asiatica) essential oils suppress 3-hydroxy-3-methylglutaryl-co-enzyme A reductase expression in vitro and in vivo and show hypocholesterolaemic properties in mice . British journal of nutrition, 2008, vol. 99, no. 1, p. 67-75. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature